These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 14592920)
1. Lambert-eaton myasthenic syndrome: diagnosis and treatment. Sanders DB Ann N Y Acad Sci; 2003 Sep; 998():500-8. PubMed ID: 14592920 [TBL] [Abstract][Full Text] [Related]
15. Current therapy for Lambert-Eaton myasthenic syndrome: development of 3,4-diaminopyridine phosphate salt as first-line symptomatic treatment. Quartel A; Turbeville S; Lounsbury D Curr Med Res Opin; 2010 Jun; 26(6):1363-75. PubMed ID: 20377318 [TBL] [Abstract][Full Text] [Related]
16. Lambert-Eaton myasthenic syndrome: clinical diagnosis, immune-mediated mechanisms, and update on therapies. Sanders DB Ann Neurol; 1995 May; 37 Suppl 1():S63-73. PubMed ID: 8968218 [TBL] [Abstract][Full Text] [Related]
17. [Lambert-Eaton myasthenic syndrome]. Motomura M; Fukuda T Brain Nerve; 2011 Jul; 63(7):745-54. PubMed ID: 21747145 [TBL] [Abstract][Full Text] [Related]
18. Italian recommendations for Lambert-Eaton myasthenic syndrome (LEMS) management. Evoli A; Liguori R; Romani A; Mantegazza R; Di Muzio A; Giometto B; Pegoraro E; Rodolico C; Vigliani MC; Neurol Sci; 2014 Apr; 35(4):515-20. PubMed ID: 24481713 [TBL] [Abstract][Full Text] [Related]